GT
GelSana Therapeutics, Inc.
SEC filingBiotechnology · Aurora, CO
Amount raised$3.5Msold at filing
Total offering$3.7M$200K still open
Investors in the raise20count reported to the SEC
FiledMar 6, 2026first sale Nov 20, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mike FreemanDirector
Diana VerrilliDirector
Melissa KrebsExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.